Here are relevant reports on : artificial-nail-market
-
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030
The global Artificial Intelligence (AI) in healthcare market, valued at US$14.92B in 2024, is forecasted to grow at a 38.6% CAGR, reaching US$21.66B by 2025 and US$110.61B by 2030. Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, a gradual shift toward adopting technologies such as automation, data analytics, and cloud computing, and increasing spending on HCIT infrastructure.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Market by Offering (Infrastructure, Software, Services), Technology (ML, NLP, Generative AI), Business Function (Operations & Supply Chain, Finance & Accounting), Enterprise Application, and End User - Global Forecast to 2032
The market for artificial intelligence is slated to expand from USD 371.71 billion in 2025 to USD 2,407.02 billion by 2032, at a CAGR of 30.6% during the forecast period. The major players in the AI market include Google (US), Microsoft (US), IBM (US), Oracle (US), AWS (US), Intel (US), Salesforce (US), SAP (Germany), AMD (US), Qualcomm (US), Cisco (US), Meta (US), HPE (US), Siemens (Germany), NVIDIA (US), Baidu (China), SAS Institute (US), OpenAI (US), Huawei (China), Alibaba Cloud (China), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), iMerit (US), Telus International (Canada), Innodata (US), Sama (US), C3 AI (US), HQE Systems (US), Appier (Taiwan), Adept (US), H20.AI (US), Spot AI (US), Anthropic (US), Cohere (Canada), Inbenta (US), Character.ai (US), DeepL (Germany), Inflection AI (US), Arrow AI (US), Observe.ai (US), Anyscale (US), AI21 Labs (Israel), Persado (US), Dialpad (US), Graphcore (UK), Shield AI (US), Gamaya (Switzerland), Arthur AI (US), ADA (Canada), Mostly AI (Austria), Metropolis Technologies (US), Cerebras (US), Jasper (US), Soundful (US), Writesonic (US), One AI (Israel), Synthesia (UK), Snorkel (US), Labelbox (US), Appen (US), and Cogito Tech (US).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Artificial Lift Systems Market by Types (ESP, PCP, Rod Lift), by Component (Pump, Motor, Separator, Cable, Pump Jack, Sucker Rod), by Countries (U.S., Canada, Russia, China, Venezuela) - Trends & Forecast to 2018
Artificial lift is used to provide adequate pressure in low reservoir pressure well to thrust the crude to the surface. This process of increasing recovery in low margin production wells are supported by different types of artificial lifts such as Electric submersible pump system (ESPs), Progressive cavity pump system (PCPs), Rod Lift, Gas Lift, and Others. Artificial lift component market is the sub market of artificial lift market. ESP pump market is the largest revenue producer within component market. Apart from ESP pump, Rod lift pump and ESP motor is the next biggest revenue maker.
- Published: October 2013
- Price: $ 4950
- TOC Available:
-
Artificial Disc Replacement Market by Product Type (Metal Alloys, Ceramic, Biopolymer, SS), Disc Type (Cervical Disc, Lumbar Disc), End User (Hospitals, ASCS) – Global Forecasts to 2027
The global artificial disc replacement market is projected to reach USD 2.25 billion by 2027 from USD 1.32 Billion in 2022, at a CAGR of 11% during the forecast period. The growth in the market is attributed to the increasing number of spinal surgeries, increased demand for minimally invasive surgeries, and continued technological advancements in musculoskeletal surgeries.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The US artificial intelligence market size is projected to reach USD 750.04 billion by 2032. The key players include Microsoft (US), IBM (US), Google (US), AWS (US), NVIDIA (US), Oracle (US), and Scale AI (US), along with startups such as Anthropic (US), Cerebras (US), OpenAI (US), and Anduril Industries (US).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Industrial Artificial Intelligence Market by Offering (Hardware, Software), Technology (Deep Learning, Computer Vision, Context Awareness, and Natural Language Processing), Application, Industry, and Geography - Global Forecast to 2023
The industrial Artificial Intelligence (AI) market is witnessing significant growth because of the extensive usage of big data, industrial robots, and Internet of Things (IoT). AI-based solutions are adopted in manufacturing facilities to improve the productivity by maximizing asset utilization, minimizing downtime, and improving machine efficiency. Moreover, industrial AI is expected to enhance productivity through quality control by detecting defects and help in the predictive maintenance of factory machinery. The Industrial AI market was valued at USD 272.5 Million in 2016 and is expected to reach USD 4,882.9 Million by 2023, growing at a CAGR of 52.42% between 2017 and 2023.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence in Manufacturing Market By Processor (MPUs, GPUs, FPGAs, ASICs), Software (On-premises, Cloud), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision, Generative AI), Application - Forecast to 2030
The US artificial intelligence in manufacturing market was valued at USD 12.20 billion in 2025 and is projected to reach USD 52.31 billion by 2030; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 32.3% from 2026 to 2030. The key players in the US artificial intelligence in manufacturing market include NVIDIA Corporation (US), IBM (US), Siemens (Germany), ABB (Switzerland), Honeywell International Inc. (US), GE Vernova (US), among others.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Artificial Neural Network Market by Component (Solutions, Platform/API and Services), Application (Image Recognition, Signal Recognition, and Data Mining), Deployment Mode, Organization Size, Industry Vertical, and Region - Global Forecast to 2024
Artificial Neural Network (ANN) market is expected to grow from USD 296 million by 2024, at a Compound Annual Growth Rate (CAGR) of 20.5% during the forecast period. Major vendors in the global ANN market include Google (US), IBM (US), Oracle (US), Microsoft (US), Intel (US), Qualcomm (US), Alyuda (US), Ward Systems (US), GMDH, LLC (US), Starmind (Switzerland), NeuralWare (US), Neurala (US), and Clarifai (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Artificial Pancreas Device System (APDS) Market by Device Type (Threshold Suspended Device System, CTT System) by Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2023
Artificial Pancreas Device Systems consists of two types of devices for diabetes monitoring: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) used to calibrate the CGM. These devices are intended to reduce hypoglycemic excursions by automatically suspending insulin administration for up to two hours when an individual’s glucose level drops below a preset level, if the individual does not respond to the threshold-suspend alarm. In 2016, the MiniMed 670G System (Medtronic), a hybrid-closed loop insulin delivery system, received FDA approval. This device is the first fully automated artificial pancreas device system. It consists of an insulin pump, a glucose meter, and a transmitter, linked by a proprietary algorithm, and the SmartGuard Hybrid Closed Loop. The system can be programmed to suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values and automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
